Inhibitor development and mortality in non-severe hemophilia A

Autor: C.L. Eckhardt, J.I. Loomans, A.S. van Velzen, M. Peters, E.P. Mauser‐Bunschoten, R. Schwaab, M.G. Mazzucconi, A. Tagliaferri, B. Siegmund, S.E. Reitter‐Pfoertner, J.G. van der Bom, K. Fijnvandraat, P.W. Kamphuisen, K. Peerlinck, J. Oldenburg, E. Santagostino, J. Astermark, C.L Eckhardt, A.S van Velzen, N. Streefkerk, J.L. Loomans, A. van Eijkelenburg, A.J. Jansen, C.C. Kruijt, B. van Tienoven, A.C.G. van Baar, I.W. Corten, K. Meijer, M.R. Nijziel, N. Dors, K. Hamulyak, E. Beckers, P.P. Brons, B.A.P. Laros‐van Gorkom, W.L. van Heerde, F. Leebeek, M. Kruip, M.H. Cnossen, E. Mauser‐Bunschoten, K. Fischer, F.J. Smiers, C. Hermans, R. Klamroth, C. Escuriola‐Ettingshausen, C. Königs, P. Petrini, M. Holmström, A. Mäkipernaa, C. Male, I. Pabinger, R.D. Keenan, R. Liesner, K. Khair, T.T. Yee, D.P. Hart, S. Rangarajan, M. Mitchell, G. Thompson, S. Haya, A. Moret, A.R. Cid, V. Jimenez‐Yuste, M.E. Mancuso, M.G. Mazzuconni, C. Santoro, M. Morfini, G. Castaman, P. Schinco, G.F. Rivolta, H. Platokouki, S. McRae

Publikováno v: Journal of Thrombosis and Haemostasis, 13(7), 1217-1225. Wiley
Journal of Thrombosis and Haemostasis, 13(7), 1217-1225
Journal of thrombosis and haemostasis, 13(7), 1217-1225. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 13, 1217-25
Journal of Thrombosis and Haemostasis, 13, 7, pp. 1217-25
Journal of Thrombosis and Haemostasis, 13(7), 1217. Wiley-Blackwell

BACKGROUND: The life expectancy of non-severe hemophilia A (HA) patients equals the life expectancy of the non-hemophilic population. However, data on the effect of inhibitor development on mortality and on hemophilia-related causes of death are scar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d5b169bde53c72df8027f9087821d9f
https://research.rug.nl/en/publications/1e934363-fdf0-4dda-a41c-959edc3a8469